Industrial biotechnology - Markets and industry structure

Journal of Commercial Biotechnology

Volumn 18, Issue 1, 2012, Pages 11-21

  Festel, Gunter ^a   Detzel, Christian ^b   Maas, Ruth ^a  

^a Autodisplay Biotech GmbH   (Germany)

^b NONE

Author keywords

Biobased products; Biochemicals; Bioeconomy; Industrial biotechnology; Medicare; Renewable feedstocks

Indexed keywords

BIO-BASED PRODUCTS; BIOCHEMICALS; BIOECONOMY; INDUSTRIAL BIOTECHNOLOGY; MEDICARE; RENEWABLE FEEDSTOCKS;

BIOPOLYMERS; BIOTECHNOLOGY; HEALTH INSURANCE; INDUSTRY;

INDUSTRIAL CHEMICALS;

BIOPOLYMER; CHEMICAL AGENT; POLYMER;

BIOTECHNOLOGY; CHEMICAL INDUSTRY; CONSUMER; DRUG INDUSTRY; FINANCIAL MANAGEMENT; MARKET; REVIEW;

EID: 84858992786     PISSN: 14628732     EISSN: 1478565X     Source Type: Journal    
DOI: 10.5912/jcb.478     Document Type: Review

References (21)

1. Festel, G., Knöll, J. and Götz, H. (2004) Industrial Biotech - Influencing Production. Chemistry & Industry 7: 21-22.
2. Hermann, B.G., Blok, K. and Patel, M. K. (2007) Producing Bio-Based Bulk Chemicals Using Industrial Biotechnology Saves Energy and Combats Climate Change. Environmental Science & Technology 41 (22): 7915-7921. (Pubitemid 350133338)
3. Coons, R. (2010) Industrial Biotechnology. Chemical Week 172 (27): 22-26.
4. Festel, G. (2010) Industrial biotechnology: Market size, company types, business models, and growth strategies. Industrial Biotechnology 6 (2): 88-94.
5. Nieuwenhuizen, P. and Lyon, D. (2010) Anticipating opportunities in industrial biotechnology: Sizing the market and growth szenarios. Journal of Commercial Biotechnology 17 (2): 159-164.
6. Festel, G. (2011) Drivers and barriers for industrial biotechnology. International Sugar Journal 113 (1345): 19-23.
7. EuropaBio (2003) White Biotechnology: Gateway to a More Sustainable Future, 10 April, Brussels.
8. Dechema (2004) Weiße Biotechnologie - Chancen für Deutschland. Position Paper DECHEMA e.V.
9. EuropaBio (2005) Industrial or White Biotechnology, Brussels.
10. VDI Technologiezentrum (2006) Biokatalyse in der industriellen Produktion. Düsseldorf.
11. Joint Research Center (JRC) (2007) Consequences, Opportunities and Challenges of Modern Biotechnology for Europe, Reference Report, May 2007.
12. United States International Trade Commission (USITC) (2008) Industrial Biotechnology - Development and Adoption by the U.S. Chemical and Biofuel Industries. Investigation No. 332-481, USITC Publication 4020, July 2008, Washington.
13. Kircher, M. (2011) Industrial biotechnology becomes a key competitive factor. Journal of Business Chemistry 8 (1): 3-4.
14. Nesbitt, E.R. (2009) Industrial Biotechnology in China Amidst Changing Market Conditions. Journal of International Commerce and Economics, Vol. 2, September 2009, pp. 51-96.
15. Conseil Européen de l'Industrie Chimique (CEFIC) (2010): Facts and Figures, September 2010.
16. Festel, G., Knöll, J., Götz, H. and Zinke, H. (2004) Bio-ways to drugs. European Chemical News, 19 January, p 22.
17. Tamis, W.L.M., van Dommelen, A. and de Snoo, G.R. (2009) Lack of transparency on environmental risks of genetically modified micro-organisms in industrial biotechnology. Journal of Cleaner Production 17 (6): 581-592.
18. Bevan, M. and Franssen, M. (2006), Investing in green and industrial biotech. Nature Biotechnology 24, (7): 765-767.
19. Schneider, B. (2009) Commentary: A capital market's view on Industrial Biotechnology - proper valuation is the key for picking the right investment opportunities in stormy times. Journal of Business Chemistry 6 (3): 108-110.
20. BioIndustry Association (2009) Access to capital challenges future of UK life sciences industry - Urgent Government investment required. BioIndustry Association survey 30 March, http://www.fiercebiotech.com/press-releases/access- capital-challenges-future-uk-life-sciences-industry-urgent-government-investme.
21. EuropaBio (2009) Time for Action: The Financial Crisis and Biotech SMEs, Rev 06, September 2009, Brussels.